Sign in
4

Changes in Ownership

bioAffinity Technologies, Inc. Filed Acc 0001493152-24-003696

President, CEO acquired 24,535 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Zannes Maria President, CEO 2023-10-01 Grant or award +11,867 $1.58 $18,750 128,105 D: show line 1 in the form
Zannes Maria President, CEO 2024-01-01 Grant or award +12,668 $1.48 $18,749 140,773 D: show line 2 in the form
Loading xslF345X05/ownership.xml…